Faheem Guirgis, MD Center for Research Training
Slides from Rosemarie Fernandez, MD
RTA: Specific Aims Faheem Guirgis, MD Center for Research Training - - PowerPoint PPT Presentation
RTA: Specific Aims Faheem Guirgis, MD Center for Research Training Slides from Rosemarie Fernandez, MD Objectives The review process (why SA page is so important) What reviewers are looking for: Grantsmanship and the Review Process
Slides from Rosemarie Fernandez, MD
study section
Reviewed by committee Triaged out
Reviewer 1
Reviewer 1
Reviewers 2 &3
multivariate analysis)
*if you use these, do so sparingly and not in your Specific Aims or Abstract
This work is organized into 3 independent Aims described briefly below.
SA1: Determine the association of persistent Dys-HDL elevation with early sepsis-associated organ dysfunction, incidence of CCI and morbid outcomes after sepsis. In a prospective design, serial measures of Dys-HDL will be taken in 160 patients with sepsis who will be assessed for early cumulative organ dysfunction via Sequential Organ Failure Assessment score and followed for the development of CCI, and a composite morbid outcome (full functional dependence or death at 1 year). [H1] We hypothesize that persistently elevated Dys-HDL levels will be associated with early organ dysfunction as well as increased incidence of CCI and morbid outcomes.
The work proposed builds upon a solid foundation of preliminary data as well as considerable expertise in simulation- based training, evaluation methods, and resuscitation outcomes.
The research team has a history of successful collaboration and includes expertise in team science, simulation science, trauma
uniquely positioned to execute the proposed work.
Unlike other age groups, older adult rates of opioid use disorders (OUD) and opioid-related hospitalizations are rising. Older adults develop opioid use disorders 10 times greater than the general population, leading to a 25% increase in related hospitalizations over the past year. (numbers made up)
Tools that can assess an individual patient’s risk for OUD and opioid- related injury (ORI) prior to opioid prescribing in the ED are lacking, particularly in patients with acute pain. Existing OUD screening tools were designed for non-ED populations with persistent pain.